## Abstract Polymer scaffolds which can support cells to grow as well as deliver growth factors to the cells simultaneously have great potential for the successful regeneration of failed tissues. As popularly used vehicles to deliver anti‐cancer drugs and growth factors, microspheres also show many
In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres
✍ Scribed by Anthony Z. Faranesh; Monet T. Nastley; Cristina Perez de la Cruz; Michael F. Haller; Patrice Laquerriere; Kam W. Leong; Elliot R. McVeigh
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 245 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL‐lactic‐co‐glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethylenetriamine pentaacetic acid (Gd‐DTPA). The microspheres were characterized in terms of size, drug and contrast agent encapsulation, and degradation rate. The PLGA microspheres had a mean diameter of 48 ± 18 μm. The gadolinium loading was 17 ± 3 μg/mg polymer and the VEGF loading was 163 ± 22 ng/mg polymer. Electron microscopy revealed that the Gd was dispersed throughout the microspheres and it was confirmed that the Gd loading was sufficient to visualize the microspheres under MRI. VEGF and Gd‐DTPA were released from the microspheres in vitro over a period of ∼6 weeks in three phases: a burst, followed by a slow steady‐state, then a rapid steady‐state. Biodegradable Gd‐doped microspheres can be effectively used to deliver drugs in a sustained manner, while being monitored noninvasively with MRI. Magn Reson Med 51:1265–1271, 2004. Published 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract To improve the __in vivo__ resorption of an injectable calcium phosphate cement (CPC) for bone tissue engineering purposes, in previous experiments macroporosity was introduced by the __in situ__ degradation of incorporated gelatin microspheres. Gelatin microspheres are also suitable ca
Vascular endothelial growth factor-C (VEGF-C) is a recently characterized member of the VEGF family of angiogenic polypeptides. We demonstrate here that VEGF-C is angiogenic in vitro when added to bovine aortic or lymphatic endothelial (BAE and BLE) cells but has little or no effect on bovine microv
## Abstract We produced a chitosan/fucoidan micro complex‐hydrogel as a carrier for controlled release of heparin binding growth factors such as fibroblast growth factor (FGF)‐2. Material consisting of a soluble chitosan (CH‐LA) mixed with fucoidan yielded a water‐insoluble and injectable hydrogel
Intraarticular injection of hyaluronan (hyaluronic acid; HA) is the common way to treat osteoarthritis (OA) of knees. This treatment cannot only maintain the viscoelastic properties of knee but also release the OA pain. However, the exact molecular mechanism is unknown. In this study, after human sy
## Abstract ## Background Vascular endothelial growth factor (VEGF) gene transfer with recombinant adeno‐associated viral (rAAV) vector for ischemia heart disease therapy is being increasingly studied. However, uncontrolled long‐term expression of VEGF may cause some side effects. Therefore, an at